Qloo's proprietary cross-domain AI models uncover unexpected connections between EV buyers and off-road enthusiasts, giving automakers a new lens for product design, positioning and investment.

NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Qloo, the AI company powering cultural intelligence and taste-based inference, today highlighted new research conducted with global management consulting firm Kearney's Product Excellence and Renewal Lab (PERLab), demonstrating how artificial intelligence can reveal overlooked market opportunities by understanding the connections between consumer interests, lifestyles, and preferences.

The research, published by Kearney in its report Can rising fuel costs and a love for the outdoors open the market for off-road EVs?, combines Kearney's automotive and product strategy expertise with Qloo's proprietary Taste AI platform to examine an emerging question for automakers: could traditional off-road enthusiasts represent a significant opportunity for the next generation of electric vehicles?

The findings challenge conventional assumptions about who the next EV customer might be.

Using Qloo's cross-domain taste intelligence, researchers analyzed the cultural affinities associated with three distinct audiences: traditional off-road enthusiasts, mainstream electric vehicle buyers, and a Rivian-associated audience.

The analysis revealed that traditional off-road enthusiasts and mainstream EV buyers share substantially more cultural interests than conventional automotive segmentation might suggest.

Among the findings:

- Unexpected audience convergence: Off-road enthusiasts and mainstream EV buyers exhibited meaningful overlap across outdoor brands, entertainment, media, and lifestyle interests, challenging assumptions that these audiences occupy fundamentally different cultural worlds.

- An underserved market opportunity: The research identified potential white space for rugged, utility-focused electric vehicles in the 60,000 segment, where mainstream affordability and credible off-road capabilities have yet to converge at scale.

- Cultural signals beyond conventional demographics: Qloo's AI revealed relationships across brands, media, fashion, dining, retail, and travel that traditional vehicle ownership data or demographic analysis may overlook.

- Implications for product development: The findings suggest automakers can use cross-category consumer intelligence to inform product positioning, feature prioritization, and market-entry strategies earlier in the development process.

"Much of our work at Kearney PERLab centers on helping companies turn customer insight into better product decisions. Qloo gave us a different lens," said Alexander Bruns, Partner at Kearney. "At first, looking at interests in food, clothing, magazines, and music can feel off-topic. But those cultural signals revealed meaningful links between seemingly different audiences, including a finding we did not expect: mainstream EV buyers may have more in common with hardcore off-roaders than the industry assumes. That matters when deciding which features are essential, where differentiation is worth investing in, and where complexity can be reduced."

The study also found that the Rivian-associated audience exhibits a more design-oriented interpretation of outdoor adventure, while mainstream EV buyers share significant affinities with traditional off-road enthusiasts - suggesting room for differentiated products serving distinct consumer identities.

Understanding What Consumers Will Value Next

"Consumers don't live in industry silos, but most market research still puts them there," said Jay Alger, Co-Founder and Chief Operating Officer of Qloo. "What people love across the rest of their lives can tell you a tremendous amount about what they may value next. Our work with Kearney demonstrates how AI can uncover connections that aren't immediately obvious - whether you're designing the next generation of vehicles, entering a new market, or building more intelligent customer experiences. That's the power of understanding taste across domains."

Unlike traditional approaches that rely primarily on demographics, surveys, or historical purchasing behavior, Qloo models relationships among cultural entities and consumer preferences across categories.

Its privacy-first architecture enables organizations to explore affinities and make inferences without relying on personally identifiable information.

The approach provides a complementary intelligence layer for understanding consumers and evaluating new market opportunities.

A New Intelligence Layer for Product and Market Strategy

The Kearney research illustrates a broader application of Qloo's technology: using cross-domain AI inference to inform strategic decisions well beyond conventional personalization and recommendation systems.

By mapping relationships among culture, preference, and place, Qloo enables organizations to explore how interests in one domain may relate to opportunities in another.

These capabilities have applications across automotive, commerce, financial services, travel, hospitality, and the emerging generation of AI-powered agents - where understanding relevance and preference is increasingly important to making useful real-world decisions.

The research underscores how AI-powered cultural intelligence can complement traditional market research, helping businesses identify unexpected customer adjacencies, evaluate product concepts, and better understand what consumers value before making significant strategic investments.

The full Kearney research is available here:

Can rising fuel costs and a love for the outdoors open the market for off-road EVs?

The Q3 2026 study compared interest-defined audience cohorts, including a Rivian-affinity cohort rather than verified owners. Findings are directional and do not establish purchase intent or market size.

About Qloo

Qloo is the AI company building the intelligence layer connecting people, culture, and place. Founded in 2012, Qloo combines a proprietary cultural knowledge graph, large-scale taste signals, and machine learning models to understand and predict preferences across categories including entertainment, dining, travel, fashion, brands, and consumer products.

Through its API-first platform, Qloo powers personalization, discovery, audience intelligence, and AI grounding for organizations including American Express, Netflix, Match Group, Live Nation, and Michelin.

Qloo's privacy-first technology enables sophisticated inference without relying on personally identifiable information.

Learn more at www.qloo.com.

About Kearney

Kearney is a leading global management consulting firm. Its Product Excellence and Renewal Lab (PERLab) helps organizations improve product competitiveness through product strategy, design, engineering, and innovation.

Learn more at www.kearney.com.

SOURCE Qloo Inc.

Share this article

NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly presented awards to four outstanding leaders in T1D research whose impact has pushed Breakthrough T1D's mission forward. Award recipients include:

- Carla Greenbaum, M.D., George Eisenbarth Award for Type 1 Diabetes Prevention

- William Tamborlane, M.D., Breakthrough T1D David Rumbough Award

- Peter Thompson, Ph.D., Dr. Robert Goldstein Award

- Roy Beck, M.D., Ph.D., Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award

"Breakthrough T1D is honored to present these awards and recognize these incredible individuals who embody our mission to accelerate research toward cures for type 1 diabetes while improving the lives of those who live with it," said Breakthrough T1D Chief Scientific Officer Sanjoy Dutta, Ph.D. "This group of researchers has played a role in major scientific breakthroughs that have increased our understanding of T1D and led to technologies and therapies that have changed the course of the disease for millions around the world. We are grateful for their leadership and contributions."

George Eisenbarth Award for Type 1 Diabetes Prevention

Named after esteemed researcher George Eisenbarth, M.D., Ph.D., who provided the foundation for predicting T1D and identifying novel approaches toward prevention and cures, this award recognizes researchers who have made great contributions to preventing T1D.

Dr. Carla Greenbaum is an endocrinologist in the Center for Interventional Immunology at Benaroya Research Institute in Seattle, Washington, an institution internationally renowned for immune disease research and a highly collaborative environment with basic, translational, systems, and clinical researchers working together to accelerate bringing new science to clinical use. Dr. Greenbaum has been at the forefront of understanding the T1D disease process for almost four decades, conducting some of the first studies showing that autoantibodies predict T1D disease years before clinical diagnosis and serving as clinical center director of the Northwest Diabetes Prevention Trial (DPT-1) in the 1990s.⯠â¯

Dr. Greenbaum later served as vice chair and subsequently chair of Diabetes TrialNet, leading this National Institutes of Health (NIH) sponsored international network in conducting trials to slow or stop the disease before or after diagnosis, including the landmark trial demonstrating that teplizumab delayed the onset of stage 3 T1D. Currently, she is Co-Director of Diabetes TrialNet Clinical Hub and serves on the Scientific Advisory Board of the NIH funded Immune Tolerance Network. In addition to academic work, she actively engages with the industry to advance therapies to alter the course of T1D.â¯

Breakthrough T1D David Rumbough Award

The Breakthrough T1D David Rumbough Award acknowledges an individual who has made outstanding achievements in the field of T1D that have significantly accelerated the Breakthrough T1D mission.

Dr. William Tamborlane had a distinguished career as an academic pediatric endocrinologist and diabetes researcher. His groundbreaking study of the portable insulin pump for individuals with T1D and dedication to the families who participated in the rigorous research protocols changed the trajectory of many people's lives and had a tremendous impact on the field. He understood, with great conviction, that the achievement of glycemic targets would prevent long-term complicationsâa principle later confirmed unequivocally by the landmark Diabetes Control and Complications Trial (DCCT), the results of which were published in theâ¯New England Journal of Medicineâ¯in 1993. At the time of his retirement from Yale School of Medicine, his curriculum vitae listed over one thousand articles, book chapters, and guidance documents.

Over the course of his career, he received over 25 national and international honors, including the Juvenile Diabetes Research Foundation (JDRF, now Breakthrough T1D) Mary Tyler Moore and S. Robert Levine, M.D. Excellence in Clinical Research Award in 2006 and the American Diabetes Association Outstanding Achievement in Clinical Diabetes Research Award in 2017.

Dr. Robert Goldstein Award

Named for Dr. Robert Goldstein, who played a key role in developing Breakthrough T1D's Research department and served as chief scientific officer for Breakthrough International and Breakthrough T1D Canada for decades, the award recognizes notable early career T1D researchers who show great promise for future work in the field.

Dr. Peter Thompson is associate professor of physiology and pathophysiology in the University of Manitoba's Max Rady College of Medicine and research scientist at the Children's Hospital Research Institute of Manitoba. He completed his Ph.D. in medical genetics in 2016 studying stem cell biology at the University of British Columbia, and his postdoctoral training in islet biology and T1D at the University of California San Francisco Diabetes Center in 2020. Dr. Thompson established his independent research program as an assistant professor at University of Manitoba in 2020.

Dr. Thompson's research has focused on senescence as a mechanism contributing to beta cell dysfunction in T1D, and as a potential target for developing disease-modifying therapies. His work highlights the active role beta cells play in disease progression and points to stress response pathways that may offer long term therapeutic opportunities. Dr. Thompson's research program is funded by major national grants including from Breakthrough T1D Canada, the Canadian Institutes of Health Research, and Diabetes Canada.

Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award

This award was established in honor of Breakthrough T1D's (formerly JDRF's) International Chairman, Mary Tyler Moore and her husband, S. Robert Levine, M.D., for their extraordinary commitment to Breakthrough T1D's mission. Established in 2004, this award recognizes leaders and innovators of outstanding clinical and translational T1D research. 

Dr. Roy Beck is a physician and epidemiologist with more than 35 years of experience directing and coordinating multi-center clinical trials. He is the Medical Director of the JAEB Center for Health Research, a nonprofit clinical trial coordinating center in Tampa, Florida that he founded in 1993. Diabetes became a major focus of the JAEB Center and Dr. Beck's research after one of his children developed T1D in the 1990s.

During the last 25 years, he has directed the coordinating center for the National Institutes of Health (NIH) funded Diabetes Research in Children Network, the JDRF (now Breakthrough T1D) Continuous Glucose Monitor (CGM) Randomized Trial, the Pediatric Diabetes Consortium, the Type 1 Diabetes Exchange, and numerous CGM, automated insulin delivery system, and drug studies funded by NIH, Breakthrough T1D, the Helmsley Charitable Trust, and industry. Dr. Beck has been an author or co-author of more than 600 manuscripts in scientific journals.

Breakthrough T1D research award recipients were recognized at a ceremony in Philadelphia earlier in October 2026.

Breakthrough T1D recognizes and appreciates all the dedicated researchers who are committed to finding cures and improving the lives of those living with T1D.

About Breakthrough T1D, Formerly JDRF

As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while drivingâ¯toward cures.â¯We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition. 

About Type 1 Diabetes (T1D) 

T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all. Thisâ¯leads to dependence on insulin therapy and the risk of short and long-term complications, which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves, and heart; and even death. Globally, it impacts 9.5 million people. Many believe T1D is only diagnosed in childhood and adolescence, but diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The onset of T1D has nothing to do with diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.

While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.

Contact:

Casey Fielder

[email protected]

509-651-0087

SOURCE Breakthrough T1D, Formerly JDRF

Share this article

New state-of-the-art facility in North Carolina will strengthen supply chain resilience, expand manufacturing capacity and reinforce Bracco's long-term commitment to the U.S. market

Investment expected to create 200 jobs in Sanford, North Carolina

MILAN, October 27, 2026 /PRNewswire/ -- Bracco, a global leader in diagnostic imaging, today announced plans to invest $230 million to establish its first U.S. manufacturing facility for injectable contrast media in Sanford, North Carolina. Expected to create 200 jobs, the investment marks a significant milestone in Bracco's global manufacturing strategy, expanding production capacity and strengthening supply chain resilience in the United States, the company's largest market.

"For almost 100 years, Bracco has been guided by one purpose: improving people's lives. The United States is our largest market and home to many of the patients we serve," said Fulvio Renoldi Bracco, Vice Chairman and CEO of Bracco Imaging. "Producing injectable contrast media here in Sanford brings our supply closer to American hospitals and patients and makes it even more resilient. We chose North Carolina for its talent and life sciences ecosystem. As a family-owned company, we invest for the long term, and we look forward to growing with the Sanford community for decades to come."

The new state-of-the-art sterile manufacturing facility will complement Bracco's established production operations across Europe, Asia and Canada, creating a more geographically diversified and resilient manufacturing network. With additional sterile manufacturing capacity in the United States, Bracco will be better positioned to meet growing demand, respond to customer needs and support reliable access to injectable contrast media used in diagnostic imaging.

The facility will be developed with a focus on advanced manufacturing capabilities and the high standards of quality that underpin Bracco's global operations, supporting the company's mission to advance diagnostic imaging and improve patient care.

Bracco selected Sanford, North Carolina, for its skilled workforce, established life sciences ecosystem and supportive environment for advanced manufacturing. The investment is expected to create 200 jobs across manufacturing, engineering, technical operations, quality, warehousing and administrative functions, contributing to the continued growth of the state's life sciences sector.

The project builds on Bracco's nearly century-long history of innovation in diagnostic imaging and reflects its continued investment in the manufacturing capabilities needed to support healthcare professionals and patients worldwide.

The press release issued by the North Carolina Department of Commerce on the investment can be viewed here.

The press release issued by the Sanford Area Growth Alliance on the investment can be viewed here.

About Bracco

Bracco Group, founded in 1927, is a global leader in diagnostic imaging committed to advancing healthcare and improving people's lives by shaping the future of prevention and precision medicine.

The company operates in the healthcare sector in more than 100 countries, with a workforce of over 4,000 employees and consolidated annual revenues of approximately â¬2 billion, with a global footprint.

With a strong commitment to innovation, investing around 9% of its reference turnover in research and development, Bracco develops and provides a broad portfolio of pharmaceutical products for diagnostic imaging, including contrast agents for X-ray, computed tomography and magnetic resonance imaging, as well as microbubbles for contrast-enhanced ultrasound and molecular imaging agents such as radioactive tracers and novel positron emission tomography imaging agents, alongside artificial intelligence-based solutions. It is also a global market leader in advanced contrast management technologies for cardiovascular angiography and radiology imaging.

Discover more at www.bracco.com.

Media Contacts:

Bracco Press Contact:

Alessandra Vulpiani

Bracco Imaging, Senior Marketing Communication Manager

[email protected]

Shannon Moore

Vice President, Global Health Media on behalf of Bracco Imaging

T: 714-348-4838

[email protected]

Share this article

EverPeak® Names Patrick Daley Chief Underwriting Officer

Underwriting leader with 30+ years of experience in complex property, programs, and specialty risk joins EverPeak Insurance to strengthen its appetite for complex and hard-to-place risks

DENVER, Oct. 27, 2026 /PRNewswire/ -- EverPeak Insurance today announced the appointment of Patrick K. Daley, CPCU, as Chief Underwriting Officer. Daley has more than 30 years of experience underwriting large, complex, and hard-to-place risks at carriers including Zurich Insurance, The Hartford, and GuideOne Insurance.

As Chief Underwriting Officer, Patrick Daley will lead underwriting strategy and quality standards across all EverPeak lines of business. EverPeak is built for businesses that don't quit, and Daley's record of underwriting difficult, volatile, and nonstandard exposures aligns with that purpose.

"Patrick has built his career on underwriting the risks that demand real judgment, discipline, and creativity," said Kathy Kranz, President of EverPeak. "As EverPeak continues to expand its offerings, his expertise in complex and hard-to-place risk is exactly what we need."

Key facts

- Who: Patrick K. Daley, CPCU

- New role: Chief Underwriting Officer, EverPeak Insurance

- Announced: Oct. 20, 2026, Denver

- Experience: 30+ years in insurance underwriting

- Specialties: Complex property, programs, specialty, and hard-to-place risk

- Prior employers: Glatfelter Insurance Group, GuideOne Insurance, The Hartford, Zurich Insurance, Swiss Re, CNA Re, GE Insurance, Chubb

- First priorities: New Workers' Compensation Middle Market value proposition; BOP relaunch and cross-selling

Patrick Daley's career in complex risk underwriting

Patrick Daley has spent his career in the areas where underwriting is hardest.

- Glatfelter Insurance Group (2024â2026): Head of Glatfelter Underwriting Services.

- GuideOne Insurance (2022â2023): Chief Underwriting Officer. During a turbulent period for the company, he led the re-underwriting of multiple portfolios, including its Property & Casualty E&S book, its Programs business, and its Church business. That work contributed to an investment by an outside organization that secured the company financially.

- The Hartford (2017â2022): Head of Large Property, leading underwriting for some of the largest and most complex property exposures in the market.

- Zurich Insurance (2007â2017): Held four leadership roles over ten years: Head of Alternative Programs, Head of Property, Chief Underwriting Officer â Global Corporate, and Senior Vice President of Property.

- Early career: Underwriting roles at Swiss Re, CNA Re, GE Insurance, and Chubb.

Across his career, Daley has established go-to-market line of business strategies, developed underwriting quality standards, optimized reinsurance strategies, managed catastrophe aggregations, built pricing models, expanded the use of predictive analytics, established underwriting training programs, and launched new products.

Patrick Daley's priorities at EverPeak

Daley's first priorities at EverPeak include building a new value proposition for the company's Workers' Compensation Middle Market business, which has long relied on deep data analysis, technology, and service. He will also lead the relaunch of Attune's BOP (Business Owner's Policy) product and the cross-selling of BOP and other products to EverPeak's workers' compensation customers.

Patrick Daley's credentials and education

Daley holds the Chartered Property Casualty Underwriter (CPCU) designation, an MBA from DePaul University's Kellstadt School of Business, and a bachelor's degree from Wake Forest University.

About EverPeak® Insurance

EverPeak Insurance is a workers' compensation insurance provider offering comprehensive coverage and market-leading service for businesses across the United States. EverPeak's approach to care draws on Pinnacol Assurance's 100+ years of underwriting, claims, and risk management experience. EverPeak covers the hardest-working businesses and partners with insurance agents who strive to offer the best protection to businesses with the toughest risks. Learn more at everpeak.com.

Media Contact:

Liz Johnson, Director, Public Relations, EverPeak Insurance

720.939.7238 (mobile) | [email protected]

SOURCE EverPeak Insurance

Share this article

- Glob.AI complements its AI Pods delivery units with Glob.AI OS, a unified governance layer that keeps organizations sovereign, contextualized and secure, with the intelligence to route requests to 320+ AI models, connect data sources and systems, and act as a repository for agents to be created and executed at scale

- Glob.AI is Globant's AI-Native Services Platform: enterprises pay for outcomes or consumption, rather than hours or seats. AI-Native Services engagements have delivered up to 7Ã faster legacy modernization and 3Ã faster product discovery.

NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Globant (NYSE: GLOB) today expanded Glob.AI, its AI-Native Services Platform, with Glob.AI OS, a unified layer to govern and adopt AI across the enterprise, making AI controllable, contextual and scalable.

Most enterprises already use AI in many places at once: several models, teams building their own agents, tools connected to sensitive data, and spend spread across vendors. The problem isn't capability, it's scaling it across the enterprise: turning access to AI into production outcomes, with governance, accountability and security. Glob.AI OS is the governed foundation underneath every AI call, supporting identity, agent lifecycle management, cost visibility and auditability, through:

- Intelligence Hub: connects 320+ open source and closed models from 25+ providers and routes each task to the most cost-efficient option, optimizing token consumption across AI Pods and everyday work alike.

- Corporate Hub: connects AI to the company's data, systems, identity and industry knowledge, so context doesn't have to be rebuilt every time something new starts.

- Agentic Hub: refines and tests agentic solutions before deployment, and orchestrates their execution with runtime governance.

- Token Vault: governs who uses AI, what they can do and how it operates, with budgets, cost attribution, an auditable record of AI activity and real-time visibility into where the investment lands.

Glob.AI OS enables daily AI adoption through Glob.AI Apps, which bring governed AI into everyday work. With Glob.AI Apps, people across the organization get answers, delegate tasks, build software with any coding agent and use specialized agentic solutions from Globant and its partners, and teams scope and run projects with AI Pods from the same place. Glob.AI OS runs as SaaS or in the client's own cloud, and is accessible through chat, web, desktop, command-line interfaces or headlessly via MCP. Client data stays their own and never trains anyone's model.

"We are making it seamless for global leaders to take the best out of AI leveraging Globant's 23+ years of experience working with top companies in almost every industry in a completely reshuffled engagement model where they only pay for outcomes," said Sarab Narang, CEO of Glob.AI. "Glob.AI OS lets a large organization put AI in the hands of many teams and many agents, while keeping one clear answer to who used it, on what data, at what cost, and under which policy."

Glob.AI, the AI-Native Services Platform for Enterprise AI Adoption

Glob.AI is built on two pillars that work together: AI Pods and Glob.AI OS. Together they let enterprises move from experimentation to production-ready outcomes, paying for outcomes or consumption rather than hours or seats.

AI Pods are human-supervised delivery units that combine documented workflows, AI agents and expert supervision from Globant, including Forward Deployed Engineers. Agents handle execution-intensive tasks while experts supervise outputs and remain accountable for delivery. Each AI Pod addresses a specific business challenge, from software development and testing to application modernization and ongoing operations, and runs on Glob.AI OS, so every Pod inherits the same governance, security and institutional knowledge as the rest of the organization's AI.

Traditional technology services models typically organize delivery around hours, team size and available capacity. But as AI changes how work is performed, enterprises have an opportunity to rethink the relationship between the resources they purchase and the results they receive.

"AI has taken the world by storm, but having access to technology is not enough. Enterprises need a new

way to put it to work, with more transparency, control and speed. Glob.AI brings intelligence, enterprise context and the agentic layer together so organizations can access AI Native Services and ship working, production-ready outcomes through AI Pods," said MartÃn Migoya, Co-Founder and CEO of Globant. "We are extremely proud of what we are bringing to the world. Our deep expertise and experience in delivering business solutions for the best companies in the world has prepared us for this exact moment. We're not just reinventing services; we have created a new category of delivering business outcomes."

Measurable impact across real-world Customer Success

AI Pods, a layer of Glob.AI, are already in use by several Fortune 500 organizations across media, entertainment, professional services, and finance, delivering measurable gains in speed, effort, scale and operating efficiency.

- FIFA achieved a 20% increase in throughput efficiency while maintaining or improving quality rates.

- YPF reduced contract timelines by up to 40%.

- PharmaMar gained insights 15Ã faster in oncology research.

- A leading commercial bank completed its COBOL migration in two months, compared with the 14 months projected using a traditional approach.

Visit Glob.AI to get early access.

About Globant

Globant (NYSE: GLOB) is a global AI-native services company that helps organizations reinvent themselves and drive measurable business results by combining technology, creativity and innovation with AI at its core. Through Glob.AI, its AI-native technology services model and its signature AI Pods, agentic service units supervised by experts, the company delivers enterprise-grade technology services tied directly to core business metrics.

Present across 30+ countries, Globant operates a network of industry-specific AI Studios and partners with global brands including FIFA, Google, Riot Games, the LA Clippers and Santander. Recognized by IDC MarketScape as a Worldwide Leader in Experience Design Services (2025) and a Leader in AI Services (2023), Globant's work is featured as business case studies at Harvard, MIT and Stanford. The company collaborates with leading technology platforms including Anthropic, NVIDIA, AWS and Unity.

SOURCE Globant

Share this article

VidantaWorld Mexico Open Best Bets and Golf Odds:

The Butterfield Bermuda Championship was shortened to a 54-hole event because of unplayable conditions from the strong winds. However, play did not end until Monday morning when 54-hole co-leaders Austin Smotherman and Seamus Power went to the par-3 16th and played it three times. Smotherman, a pre-tournament price of 33-1, won the playoff on the third playoff hole and won his second start in a row. Three weeks ago, Smotherman won his maiden PGA Tour event in his 100th start at the Bank of Utah Championship. This column had to settle for second again with Power. Smotherman locked himself into next season’s first two Signature events — AT&T Pebble Beach Pro-Am and Genesis Invitational — while Power locked up his full PGA Tour card for 2027.

As the 2026 PGA Tour season winds down, the tour begins a two-week stint in Mexico, first at VidantaWorld for the Mexico Open. The FedExCup Fall is still in the balance, with players trying to get into FedExCup spots 51-60, like Smotherman did, to earn entry into the Signature Events. Others are looking to finish inside the Top 100 to keep full PGA Tour status for 2027, like Power did last week.

None of that is of concern for U.S. Open champion Wyndham Clark (12-1), who won three times this season and, at No. 5 OWGR, is one of only three top-50 players in this week’s field.

Tom Kim (+1800), who finished third to Clark at the U.S. Open, sits as second choice this week.

Doug Ghim (18-1) finished eighth here in 2024 and was the runner-up to Smotherman three weeks ago at the Bank of Utah Championship as he inches closer to his first PGA Tour victory. Also at 18-1 is Ben James, who has four top-5 finishes since turning professional in June, but did miss the cut last week in Bermuda.

After winning three times in 2025, including at the World Wide Technology Championship, which is next week’s event, Ben Griffin (20-1) is still looking for his first victory in 2026.

A trio priced at 28-1 includes John Keefer, who has five top-10 finishes, including two thirds, in his current rookie season on tour, Cotey Conners, who finished third last week and missed out on joining Monday’s playoff by one stroke; and Marco Penge, who currently ranks 53rd in the OWGR and is looking to get into the top 50 by year’s end, which earns exemptions into all four majors.

Three weeks ago, Blades Brown (33-1) finished runner-up in the Korn Ferry Tour Championship to finish ninth on the points list and therefore made history by becoming the youngest player to ever earn a PGA Tour card via the Korn Ferry Tour at 19 years, 4 months old.

Brian Campbell (225-1) won this event in a playoff last year in the spring of 2025 over Aldrich Potgieter (80-1), who we had tipped in this column. Campbell’s drive on the first playoff hole was headed toward the trees before he got an incredible bounce, and the ball ended up back in the fairway. Although he was almost 100 yards behind Aldrich Potgieter, he still had a shot. He ripped a fairway wood to wedge distance and rolled in a four-footer for birdie. When Potgieter missed a six-foot birdie attempt, Campbell had won.

Tony Finau (80-1) won this event in 2023 after finishing runner-up the year prior. Currently at No. 107 in the FedExCup Fall, Finau is one of the many players fighting to finish in the Top 100 in order to ensure full PGA Tour playing privileges in 2027.

The Event

The VidantaWorld Mexico Open was first played as the Mexican Open in 1944 at the Club de Golf Chapultepec. It was an event on the Tour de las Américas between 2003 and 2006 and was co-sanctioned by the European Challenge Tour from 2004 to 2006. Then, it became a Nationwide Tour event in 2008. In 2013, the tournament was moved to March and became an official event for PGA Tour Latinoamérica. The tournament would also be moved to Club de Golf Mexico.

In 2022, the tournament became an official event on the PGA Tour, awarding 500 FedEx Cup points to the winner, plus the normal perks for winning a PGA Tour event, including a two-year tour exemption, and invitations to the Masters, PGA Championship and the Players Championship.

The Field

120 players are in this week’s field playing for a $6 million purse and valuable FedExCup Fall points. As mentioned above, only three players in the OWGR Top 50 — Wyndham Clark (5), Ben Griffin (28) and Tom Kim (30) — are here this week.

The Course

Vidanta World is a golf destination in the town of Puerto Vallarta, Mexico. Set on the Pacific Coast, Grupo Vidanta, within its Vallarta resort complex, has several golf courses, the newest of which is the Norman Signature Course.

Designed by Greg Norman and opened in 2015, it is only accessible via the world’s longest golf cart suspension bridge. The course itself is set on the Ameca River, with a few holes running alongside. It is a resort course by nature, with the course seemingly flat, with plenty of lakes and ponds forming hazards around the setup. The layout features panoramic views of the Sierra Madre mountain range. This design is surrounded by trees, native grasses and jungle patches.

Vidanta Vallarta is a par-71 course that measures out to 7,337 yards, playing around 100 yards shorter this year, and players will see a rerouting and new design specifically focused on Nos. 4, 8, 17 and 18. The fourth was completely redesigned to a 423-yard par 4 from a 520-yard hole. Hole Nos. 18, 9, 1 and 10 are now situated in a single quadrant to improve fan experience, while No. 17 will feature a stadium-style build-out. No. 11 changed from a par-3 to a par-4 while No. 13 is now a drivable par-4 (changed from a par-3). No. 15 is also now a par-3 (changed from a par-4).

The fairways are the fifth widest on tour at 41 yards on average. The Paspalum rough has been grown out to 2.5 inches to provide more of a penalty for missing fairways.

The track is comprised of Paspalum throughout. Paspalum is a very common grass used on coastal courses that is known for being sticky. This means that drives will not roll out as much on the wide fairways and will stop much quicker on the greens. The 7,000-square-foot-average greens (10th largest on tour) should run around an average speed of 11.5 on the stimpmeter.

Bunkers are few (55), but water hazards are plentiful, with 12 water danger holes on the layout.

The length of the course plus the coastal winds are the primary defenses at Vidanta Vallarta, and the winds, especially in the later afternoon, can cause higher scores.

Correlated courses include TPC Craig Ranch, Coco Beach, Corales, TPC San Antonio, Congaree, and Plantation Course at Kapalua. Coco Beach (Puerto Rico Open) and Corales (Corales Puntacana Championship) are both resort-style courses that also feature Paspalum throughout their respective layouts. TPC San Antonio (Valero Texas Open) is another Norman design. TPC Craig Ranch (AT&T Byron Nelson) and Congaree (2021 Congaree Championship) are also courses that favored bombers with wide fairways and non-penal rough.

Weather

Rain is probable for the first two days of competition. Paspalum grass is soft anyway where the ball sticks to the playing surface, so the rain should make it even softer, making carry distance even more important.

Mexico Open Recent History/Winners

2025: Brian Campbell (-20/264); 250-1*

2024: Jake Knapp (-19/265); 50-1

2023: Tony Finau (-24/260); 8-1

2022: Jon Rahm (-17/267); 5-1

Playoff win over Aldrich Potgieter – *

Statistical Analysis

Jake Knapp led the field here two years ago for Strokes Gained: Approach on the way to his maiden PGA Tour victory and Brian Campbell was fourth in the category last year.

Strokes Gained: Approach — Average Per Round (Last 24 rounds)

- Corey Conners 0.91

- Blades Brown 0.85

- Tom Kim 0.82

- Jackson Suber 0.79

- Ben James 0.78

- Emiliano Grillo 0.75

- Joel Dahmen 0.72

- William Mouw 0.66

- Luke Clanton 0.65

- Davis Chatfield 0.62

- Billy Horschel 0.61

- Trace Crowe 0.57

- Zac Blair 0.53

- Ben Griffin 0.53

- David Ford 0.48

- Kevin Roy 0.48

- Kris Ventura 0.47

- Aaron Wise 0.44

- Doug Ghim 0.44

- Paul Peterson 0.43

A plurality (around low 40%) of the approach shots into these greens will be from 200 yards and out.

Average Proximity Toward the Hole — Approaches 200+ Yards (2025 PGA TOUR season)

- Isaiah Salinda 37′ 1″ (feet, inches)

- Jackson Suber 39′ 6″

- Neal Shipley 43′ 0″

- Rico Hoey 43′ 1″

- Trace Crowe 43′ 4″

- Adrien Dumont De Chassart 44′ 2″

- Kevin Roy 45′ 2″

- Taylor Pendrith 45′ 6″

- Kris Ventura 45′ 9″

- Doug Ghim 46′ 1″

- Joel Dahmen 46′ 8″

- William Mouw 46′ 9″

- Harry Higgs 46′ 9″

- Davis Chatfield 47′ 2″

- Ben James 47′ 5″

- Blades Brown 47′ 6″

- David Skinns 47′ 7″

- Paul Peterson 47′ 7″

- Lee Hodges 47′ 8″

- Ben Martin 48′ 0″

Vidanta Vallarta has some of the widest fairways on the PGA Tour, so you can “grip it and rip it” here off the tee.

Average Driving Distance (Last 24 rounds)

- Aldrich Potgieter 308.7

- Marco Penge 308.3

- Johnny Keefer 306.7

- Jesper Svensson 306.4

- Gordon Sargent 305.7

- Rasmus Højgaard 305.1

- Pontus Nyholm 304.5

- Ryder Cowan 303.7

- Pierceson Coody 302.9

- Sudarshan Yellamaraju 302.8

- Christo Lamprecht 302.7

- Neal Shipley 302.3

- Jimmy Stanger 302.2

- Wyndham Clark 302.0

- Rasmus Neergaard-Petersen 301.8

- Steven Fisk 301.8

- Isaiah Salinda 301.6

- Doug Ghim 301.5

- Haotong Li 301.5

- Alejandro Tosti 300.9

Paspalum fairways are slower and have very little runout, so Carry Distance measures the distance from tee to the point of ground impact where a valid radar measurement is taken.

Carry Distance (Last 24 rounds)

- Aldrich Potgieter 320.5

- Johnny Keefer 311.8

- Jesper Svensson 310.8

- Gordon Sargent 310.6

- Rasmus Højgaard 309.4

- Pontus Nyholm 307.1

- Davis Riley 303.5

- Taylor Pendrith 302.9

- Cam Davis 302.6

- Steven Fisk 301.6

- Wyndham Clark 301.3

- Kris Ventura 301.2

- Trace Crowe 301.1

- Rico Hoey 301.0

- Jimmy Stanger 300.8

- Ben Griffin 300.1

- Pierceson Coody 299.8

- Hayden Springer 299.6

- Tony Finau 299.4

- Jackson Suber 298.

BRENTWOOD, Tenn., Oct. 27, 2026 /PRNewswire/ -- Ovation Healthcare has released a new playbook, From Opportunity to Impact: Five Strategies for Turning RHTP Funding into Sustainable Rural Transformation, to help rural hospitals navigate the Rural Health Transformation Program (RHTP) and translate funding opportunities into meaningful, long-term improvements.

Experience the full interactive Multichannel News Release here: https://www.multivu.com/ovation-healthcare/9385252-en-ovation-healthcare-playbook-help-rural-hospitals-rhtp-funding-lasting-transformation

The Centers for Medicare & Medicaid Services awarded the full $50 billion authorized for the program to all 50 states, providing $10 billion annually from fiscal year 2026 through fiscal year 2030. The program presents a significant opportunity for rural hospitals to strengthen financial performance, expand access to care, and develop the capabilities needed to serve their communities.

While securing funding is an important first step, lasting impact depends on how hospitals align investments with strategic priorities, build implementation capacity and plan for sustainability beyond the five-year funding period. With states progressing through different stages of application, review, award and implementation, rural hospitals must understand their state's priorities and prepare to act as opportunities emerge.

"RHTP creates an important opportunity for rural hospitals to advance strategic initiatives that strengthen their organizations and the communities they serve," said Jessie Neitzer, Executive Strategic Advisor at Ovation Healthcare. "Success will depend on thoughtful planning, strong partnerships, and the ability to translate available resources into measurable outcomes that support long-term sustainability."

The new playbook outlines five strategies to help rural hospitals prepare for and maximize RHTP funding:

- Understand state priorities and funding opportunities.

- Demonstrate readiness to execute.

- Build collaborative partnerships.

- Use early funding to prepare for implementation.

- Coordinate funding and plan for sustainability.

Through this resource, Ovation Healthcare aims to help rural hospitals approach RHTP with a clear strategy for turning available funding into lasting organizational and community benefits.

Download From Opportunity to Impact to strengthen financial stability, build operational resilience, and support long-term success.

About Ovation Healthcare

Headquartered in Brentwood, Tenn., Ovation Healthcare is partnered with 500+ clients in 48 states from critical access hospitals to large health systems. For 50 years, Ovation Healthcare has supported independent healthcare through a portfolio of shared services including leadership advisory, spend management, revenue cycle management, and technology designed to provide scale and efficiency to hospital business operations. To learn how, visit OvationHC.com, connect with us on LinkedIn, or contact [email protected].

SOURCE Ovation Healthcare

Share this article

- New routes deliver Alaska Airlines' largest-ever nonstop schedule from Anchorage in 2027

- First-ever nonstop service brings Anchorage and Tokyo Narita closer beginning Spring 2027

- New nonstop service to Austin, Nashville, and Dallas provide Alaskans with nonstop access to more of the United States

SEATTLE and ANCHORAGE, Alaska, Oct. 27, 2026 /PRNewswire/ -- Alaska Airlines will launch its first nonstop service between Anchorage and Tokyo Narita* next spring, creating a convenient new connection between Alaska and the Asia-Pacific region. The route will operate seasonally between Ted Stevens Anchorage International Airport and Narita International Airport.

"Alaska Airlines has connected Alaskans to the people and places that matter since 1932, and we're thrilled to connect Alaska and Japan," said Alaska Airlines Regional Vice President Marilyn Romano. "This long-requested route will open new opportunities for tourism and commerce, bringing our distinctive hospitality to more travelers and strengthen our growing global network."

Operated on a Boeing 737 MAX 8, the AnchorageâTokyo Narita flight is designed to help guests feel comfortable, cared for and connected throughout the journey. In First Class, guests enjoy priority boarding, recliner seats, and elevated, multi-course dining, starting with Alaska's Signature Charcuterie. For a more restful experience, plush Filson-designed blankets, pillows and a Filson travel amenity kit featuring Salt & Stone products are provided. First Class guests also have access to the Alaska Lounge in Anchorage with West Coast-inspired light meals, wines, brews and cocktails in a relaxing space. Main Cabin and Premium Class guests can settle in with a complimentary meal, including a hot entrée and dessert, with vegetarian options available. Additionally, Premium Class guests can enjoy a curated selection of complimentary West Coast non-alcoholic and alcoholic beverages. Atmos⢠Rewards members will enjoy free Wi-Fi thanks to T-Mobile on select flights as installation of ultra-fast Starlink Wi-Fi continues across Alaska's MAX 8 narrowbody fleet.

"The people of the state of Alaska are ready to welcome leisure and business travelers to Anchorage on Alaska Airlines," said The Honorable Mike Dunleavy, Governor of Alaska. "As the only U.S. domestic carrier serving Tokyo with scheduled service, the opportunities to see the Northern Lights or visit Denali National Park are closer than ever. We also appreciate the many resource and business partnerships in Japan and see those ties strengthening in the future with easy, nonstop flights."

Starting today through October 31, round-trip introductory fares start at $999 for travel from Anchorage to Tokyo Narita from May 13 through June 7, 2027, subject to availability. Tickets are on sale now at alaskaair.com and hawaiianairlines.com. All new routes are subject to government approval. Terms and conditions apply; round-trip purchase required.

The Tokyo launch anchors another expansion of Alaska Airlines' Anchorage network in 2027, including new seasonal nonstop service to Nashville, Austin, and Dallas-Ft. Worth. Together, the new routes will create the largest nonstop schedule from the state of Alaska in the airline's history, expanding access to key destinations and reinforcing its commitment to the state as it celebrates 95 years of service next year.

"Our ambitions are global, but our foundation remains the same. From the beginning, Alaska Airlines has connected communities across Alaska, the West Coast and beyond," said Alaska Airlines Regional Vice President Marilyn Romano. "From Anchorage to Tokyo and destinations around the globe, we're building on that legacy and giving our guests more ways to explore the world with Alaska Airlines."

New nonstop routes from Anchorage in 2027

Schedules (All time zones local):

*Flight mentioned in this announcement is subject to government approval.

FAQ:

- When will Alaska Airlines launch nonstop service between Anchorage and Tokyo? Alaska Airlines plans to launch nonstop service between Ted Stevens Anchorage International Airport and Narita International Airport on May 13, 2027.

- How often will the AnchorageâTokyo route operate? The route will operate daily in the summer through Sept. 7, 2027 and three times weekly in the winter, beginning January 2028.

- What aircraft will operate the AnchorageâTokyo Narita route? The route will be operated with a Boeing 737 MAX 8 aircraft.

- Why is the Anchorage â Tokyo Narita being flown on a 737 MAX 8 instead of one of the new 737 MAX 10s? The MAX 8 has a longer range than the MAX 10 and is the only 737 in our fleet capable of serving this route.

- Why is Alaska Airlines adding service between Anchorage and Tokyo? The new route responds to long-standing interest in direct service between Alaska and Japan while supporting tourism, commerce and expanded access across Alaska Airlines' growing global network.

- What other new nonstop routes from Anchorage are planned for 2027? Alaska Airlines plans to add new seasonal nonstop service from Anchorage to Nashville, Austin, and Dallas-Ft. Worth.

About Alaska, Hawaiian and Horizon

Alaska Airlines, Hawaiian Airlines and Horizon Air are subsidiaries of Alaska Air Group, and McGee Air Services is a subsidiary of Alaska Airlines. We are a global airline with hubs in Seattle, Honolulu, Portland, Anchorage, Los Angeles, San Diego and San Francisco. We deliver remarkable care as we fly our guests to more than 140 destinations throughout North America, Latin America, Asia, the Pacific and Europe. Guests can book travel at alaskaair.com and hawaiianair.com. Alaska and Hawaiian are members of the oneworld© alliance. Members of our Atmos⢠Rewards loyalty program can earn and redeem points with oneworld airlines and our additional global partners that serve over 1,100 worldwide destinations. Learn more about what's happening at Alaska and Hawaiian at news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."

SOURCE Alaska Airlines

Share this article

Technology leader and healthcare entrepreneur to guide LifeLogics into its next chapter with a focus on innovation, customer experience, and advancing technology across organ donation and transplantation.

ROSSVILLE, Md., Oct. 28, 2026 /PRNewswire/ -- LifeLogics, a nonprofit technology company serving the organ and tissue donation and transplantation community, today announced the appointment of Ankit Mathur as Chief Executive Officer.

Mathur brings more than two decades of experience in technology, healthcare, and organizational leadership to LifeLogics, most recently serving as Chief Technology Officer of United Network for Organ Sharing (UNOS). His appointment comes as LifeLogics looks to strengthen its technology platforms, deepen customer partnerships, and help advance the organ donation and transplantation ecosystem.

"Ankit brings a rare combination of healthcare technology experience, entrepreneurial leadership, and a deep understanding of the organ donation and transplantation community," said Mathew Moss, Chair of the LifeLogics Board of Directors. "As LifeLogics enters its third decade, we see a tremendous opportunity to build on the organization's foundation while strengthening our commitment to innovation, customer partnerships, and operational excellence. We're confident Ankit is the right leader to help us realize this vision."

As CEO, Mathur will lead LifeLogics through its next phase of growth and modernization, with a focus on strengthening the company's partnerships with organ procurement organizations (OPOs), advancing its technology platforms, improving the customer experience, and expanding interoperability across the donation ecosystem.

"Behind every organ donation is a family navigating one of the most difficult moments of their lives. The work our customers do every day to honor those gifts and help save lives is extraordinary, and LifeLogics has an important responsibility to support them," said Mathur.

"That responsibility goes beyond building great technology. It means being a trusted partner, providing the service and support our customers deserve, and making their work easier so they can focus on what matters most. I'm excited to work alongside our customers and the LifeLogics team to build on the company's foundation while raising the bar for what our customers should expect from their technology partner."

At UNOS, Mathur helped guide technology strategy and modernization initiatives supporting the nation's organ donation and transplantation system. Previously, he was Chief Delivery Officer for the U.S. Digital Service at the White House. Earlier in his career, Mathur founded Roundtrip, a healthcare technology company ensuring patients have reliable access to transportation. Mathur is a three-time graduate of Virginia Commonwealth University and serves on the boards of the Richmond Technology Council (rvatech/) and VCU's School of Business Foundation.

ABOUT LIFELOGICS

Founded in 2006 with the support of a consortium of organ procurement organizations, LifeLogics is a nonprofit technology company providing software and technology services to the organ and tissue donation community. Its solutions include TrueNorth, a donor management platform for organ procurement organizations; Copernicus, an interoperability platform connecting hospital electronic medical record systems with OPOs; and donor registry technology supporting state and national donation programs.

For more information, visit www.lifelogics.org.

Media Contact: Tim Bourgeois at [email protected] or 508-561-9763.

SOURCE LifeLogics, Inc.

Share this article

What Does Honeywell Aerospace, Inc.'s 23.16% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Suit alleges Honeywell Aerospace, Inc. failed to disclose key facts to investors from June 29, 2026 through September 1, 2026; lead plaintiff deadline is November 23, 2026

BENSALEM TOWNSHIP, Pa., Oct. 27, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith today reported that a securities class action lawsuit is pending against Honeywell Aerospace, Inc. ("Honeywell Aerospace" or the "Company") (NASDAQ: HONA) on behalf of investors who acquired its securities from June 29, 2026 through September 1, 2026. The Honeywell Aerospace, Inc. case, Green v. Honeywell Aerospace, Inc., et al., was filed on September 22, 2026 in the U.S. District Court for the District of Arizona (Case No. 2:26-cv-06779).

Investors with losses on Honeywell Aerospace, Inc. securities can contact the Law Offices of Howard G. Smith about the Honeywell Aerospace, Inc. lawsuit before the November 23, 2026 lead plaintiff deadline.

Key deadlines and dates for Honeywell Aerospace, Inc. investors

- Lead plaintiff deadline: November 23, 2026

- Class period: June 29, 2026 through September 1, 2026

- Complaint filed: September 22, 2026

What happened?

On August 5, 2026, after the market closed, Honeywell Aerospace announced second quarter 2026 earnings, reporting that net income fell 70% year-over-year and adjusted earnings per share declined 32% year-over-year. Further, the Company slashed its full year 2026 guidance, including a reduction in expected year-over-year adjusted EBIT growth from 7%â10% to flat-to-3%.

On this news, Honeywell Aerospace's share price fell $47.17 or 23.16%, to close at $156.47 on August 6, 2026, on unusually heavy trading volume.

Then, on September 1, 2026 at approximately 2:50 p.m. ET, the Justice Department announced that Honeywell Aerospace agreed to "pay over $2 million to settle False Claims Act allegations of failing to comply with cybersecurity requirements in a U.S. Department of Defense contract."

On this news, Honeywell Aerospace's stock price fell $3.87 or 2.45%, to close at $154.24 per share on September 1, 2026, thereby injuring investors.

What is the Honeywell Aerospace, Inc. lawsuit about?

The Honeywell Aerospace, Inc. securities lawsuit alleges that, between June 29, 2026 and September 1, 2026, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Honeywell Aerospace, Inc.'s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose that: (1) a small percentage of the Company's suppliers had a "disproportionate impact" on sales; (2) those suppliers were suffering supply constraints; (3) the foregoing was reasonably likely to have a material unfavorable impact on sales and profitability; (4) the Company was under investigation for potential violations of the False Claims Act for failing to comply with cybersecurity requirements for government contracts; and (5) as a result, defendants' positive statements about Honeywell Aerospace, Inc.'s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

"The lawsuit against Honeywell Aerospace, Inc. alleges that, among other things, the Company failed to tell investors that a small percentage of the Company's suppliers had a "disproportionate impact" on sales. Honeywell Aerospace, Inc. investors who bought during the class period may be able to pursue their losses, and the November 23, 2026 deadline is where that process begins," said Howard G. Smith of The Law Offices of Howard G. Smith.

Next steps for Honeywell Aerospace, Inc. investors

Honeywell Aerospace, Inc. investors who suffered losses may contact The Law Offices of Howard G. Smith to learn about pursuing their claims.

Lead plaintiff motions in the Honeywell Aerospace, Inc. class action are due to the Court by November 23, 2026. For more information, visit the firm's website, email [email protected], or call (215) 638-4847.

If you purchased Honeywell Aerospace, Inc. securities during the class period, you may retain counsel of your choice, or you may take no action and remain an absent class member. No class has been certified in the Honeywell Aerospace, Inc. case so far.

Common questions from Honeywell Aerospace, Inc. investors

Who is eligible? Investors who acquired Honeywell Aerospace, Inc. securities from June 29, 2026 through September 1, 2026 and suffered losses may qualify for the class in the Honeywell Aerospace, Inc. shareholder lawsuit.

What is the deadline? Lead plaintiff motions in the Honeywell Aerospace, Inc. case are due by November 23, 2026.

Can I recover without being lead plaintiff? Yes, Honeywell Aerospace, Inc. investors may take no action and remain absent class members.

Does it cost anything? The Law Offices of Howard G. Smith works on contingency, meaning Honeywell Aerospace, Inc. investors owe no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid solely from a recovery, if achieved, and require court approval.

About The Law Offices of Howard G. Smith

The Law Offices of Howard G. Smith has helped injured investors recover their money for more than 15 years. The firm prosecutes securities fraud, takeover, and derivative litigation against public companies and their officers, directors, and advisors in federal and state courts nationwide, and has helped clients recover hundreds of millions of dollars in losses. Clients speak directly with a lawyer, who will promptly answer any question.

Prior results do not guarantee a similar outcome.

Related links

Contact

Howard G. Smith

The Law Offices of Howard G. Smith

3070 Bristol Pike, Suite 112

Bensalem, PA 19020

Email: [email protected] 

Telephone: (215) 638-4847

www.howardsmithlaw.com

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE Law Offices of Howard G. Smith

Share this article